Clinical Trials Logo

Clinical Trial Summary

The readmission of Heart Failure (HF) patients for exacerbation HF within 30-day is unmet goal. The mail reason for readmission is excessive accumulation of fluid in patient's lung. According our data (1,2) around 40% of HF patient have excessive lung fluid at discharge from HF hospitalization ("unacceptable" residual congestion on discharge). In other words, around 40% patients are discharged from HF hospitalization prematurely when they are not ready to be discharged. Only 60% of HF patients are discharged from HF admission with "acceptable" level of residual pulmonary congestion (2). There are some techniques to assess "readiness" of HF patients for discharge. Pulmonary congestion (lung fluid accumulation) may be assessed non-invasively by measurement Brain Natriuretic Peptide (BNP), (3,4), by lung ultrasound (LUS), (5-7) and by Lung Impedance (LI) method (1,2). LUS is operator depended technique. LI and BNP techniques are most reliable methods (2) and easy to use.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04080388
Study type Interventional
Source Hillel Yaffe Medical Center
Contact Michael Kleiner Shochat, MD, PhD
Phone 972-50-6246926
Email shochat1@gmail.com
Status Not yet recruiting
Phase Phase 3
Start date September 2019
Completion date September 2021

See also
  Status Clinical Trial Phase
Recruiting NCT04751838 - Development and Validation of a Simple-to-use Nomogram for Predicting In-hospital Mortality in Acute Heart Failure Patients Undergoing Continuous Renal Replacement Therapy
Active, not recruiting NCT04618601 - Diuretic and Natriuretic Effect of High-dose Spironolactone in Patients With Acute Heart Failure Phase 4
Recruiting NCT06142474 - SGLT2 Inhibitors in Patients With ADHF During Ventilator Weaning Phase 3
Active, not recruiting NCT05603247 - The SWISSHEART Failure Network (SHFN)
Recruiting NCT03169803 - Cardiac Output Autonomic Stimulation Therapy for Acute Heart Failure (COAST-AHF) N/A
Not yet recruiting NCT06273397 - Acetazolamide or Metolazone in Acute Heart Failure N/A
Recruiting NCT03542123 - Cardiac Output Autonomic Stimulation Therapy for Heart Failure - Hemodynamic Effects N/A
Completed NCT04878263 - Evaluation and Support Care Process Within the Care Pathway of Heart Failure Patients N/A
Not yet recruiting NCT06442280 - SGLT-2 Inhibitor and High-Dose Furosemide Plus Small-Volume Hypertonic Saline Solution in Acute HF Phase 4
Completed NCT04281849 - Balance, Aerobic Capacity, Mobility and Strength in Patients Hospitalized for Heart Failure (BAMS-HF) Program N/A
Not yet recruiting NCT04403659 - Telemonitoring of Patients Admitted in Hospital at Home With Acute Decompensated Heart Failure - Pilot Study N/A
Terminated NCT03574857 - Prospective Comparison of Metolazone Versus Chlorothiazide for Acute Decompensated Heart Failure With Diuretic Resistance Phase 4
Completed NCT03136198 - B-lines Lung Ultrasound Guided ED Management of Acute Heart Failure Pilot Trial Phase 2
Terminated NCT03746002 - Diuretic Effect of Metolazone Pre-dosing Versus Concurrent Dosing Phase 4
Active, not recruiting NCT03513653 - Strain for Risk Assessment and Therapeutic Strategies in Patients With Acute Heart Failure (STRATS-AHF) Registry
Recruiting NCT06092437 - Investigating a Tailored Diuretic Algorithm in Acute Heart Failure Patients N/A
Recruiting NCT05746923 - Lesser Poland Cracovian Heart Failure Registry
Recruiting NCT06414928 - Prognostic Model Heart Failure
Completed NCT04606927 - Pragmatic Urinary Sodium-based Treatment algoritHm in Acute Heart Failure N/A
Completed NCT03200860 - Effects of Empagliflozin on Clinical Outcomes in Patients With Acute Decompensated Heart Failure Phase 2